Cassiopea Announces Very Positive Interim Analysis Phase 2 Results for Breezula® (Clascoterone) in Treating Androgenetic Alopecia
    7/16/2018

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Breezula (Clascoterone) (topical) 7.5% 2x daily 6 months
    💊 Finasteride (oral)
    💧 Minoxidil (topical) 2 years
    💧 RU58841 (topical) 5% 2x daily
    💧 Microneedling (Derminator) (topical) once a week
    the tone is 😀 positive with slightly more effective than Propecia results.

    Other terms

    Breezula® (Clascoterone) showed promising results in a Phase 2 trial for treating hair loss, being as effective as Propecia with no serious side effects. It might be released between 2021-2022, and a related acne treatment with the same active ingredient could be used in the meantime.
    View this post in the Community →

    Similar Community Posts Join

    5 / 192 results

    Related Research

    6 / 10 results